Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TELK -- Telik, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (793)	12/26/2006 11:12:31 AM
From: zeta1961	Read Replies (1) \| Respond to of 887

I listened to the CC..lots of Q's from the analysts about the 25% non-discordance of radiology reports for A-3..sounds like they will review what happened before they continue A-5 but did not explicitly say A-5 is on hold..the P2 triplicate front line nsclc has been submitted for publication/conference? so nothing revealed.. Terrible day for patients and investors..I thank all who brought their opinions here along with the analyst reports.. Of many, this solidifies for me that active control arm P2s should be a requirement.. I feel very ignorant in asking this..but what were the management mistakes that merit clearing them out?.